Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

10 Hz tACS Over Somatosensory Cortex Does Not Modulate Supra-Threshold Tactile Temporal Discrimination in Humans.

Wittenberg MA, Morr M, Schnitzler A, Lange J.

Front Neurosci. 2019 Apr 3;13:311. doi: 10.3389/fnins.2019.00311. eCollection 2019.

2.

Sepsis recognition in the emergency department - impact on quality of care and outcome?

Morr M, Lukasz A, Rübig E, Pavenstädt H, Kümpers P.

BMC Emerg Med. 2017 Mar 23;17(1):11. doi: 10.1186/s12873-017-0122-9.

3.

Identification, Synthesis, and Field Tests of the Sex Pheromone of Margarodes prieskaensis (Jakubski).

Burger BV, de Klerk CA, Morr M, Burger WJ.

J Chem Ecol. 2017 Jan;43(1):94-105. doi: 10.1007/s10886-016-0801-0. Epub 2016 Dec 21.

PMID:
28004294
4.

Application of Synthetic Peptide Arrays To Uncover Cyclic Di-GMP Binding Motifs.

Düvel J, Bense S, Möller S, Bertinetti D, Schwede F, Morr M, Eckweiler D, Genieser HG, Jänsch L, Herberg FW, Frank R, Häussler S.

J Bacteriol. 2015 Aug 31;198(1):138-46. doi: 10.1128/JB.00377-15. Print 2016 Jan 1.

5.

A chemical proteomics approach to identify c-di-GMP binding proteins in Pseudomonas aeruginosa.

Düvel J, Bertinetti D, Möller S, Schwede F, Morr M, Wissing J, Radamm L, Zimmermann B, Genieser HG, Jänsch L, Herberg FW, Häussler S.

J Microbiol Methods. 2012 Feb;88(2):229-36. doi: 10.1016/j.mimet.2011.11.015. Epub 2011 Dec 8.

PMID:
22178430
6.

Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.

Ebensen T, Libanova R, Schulze K, Yevsa T, Morr M, Guzmán CA.

Vaccine. 2011 Jul 18;29(32):5210-20. doi: 10.1016/j.vaccine.2011.05.026. Epub 2011 May 25.

PMID:
21619907
7.

Electrophysiological indices of discrimination of long-duration, phonetically similar vowels in children with typical and atypical language development.

Datta H, Shafer VL, Morr ML, Kurtzberg D, Schwartz RG.

J Speech Lang Hear Res. 2010 Jun;53(3):757-77. doi: 10.1044/1092-4388(2009/08-0123).

PMID:
20530387
8.

The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant.

Libanova R, Ebensen T, Schulze K, Bruhn D, Nörder M, Yevsa T, Morr M, Guzmán CA.

Vaccine. 2010 Mar 2;28(10):2249-2258. doi: 10.1016/j.vaccine.2009.12.045. Epub 2010 Jan 7. Erratum in: Vaccine. 2010 Apr 30;28(20):3625.

PMID:
20060510
9.

Quantitative determination of cyclic diguanosine monophosphate concentrations in nucleotide extracts of bacteria by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.

Simm R, Morr M, Remminghorst U, Andersson M, Römling U.

Anal Biochem. 2009 Mar 1;386(1):53-8. doi: 10.1016/j.ab.2008.12.013. Epub 2008 Dec 24.

PMID:
19135022
10.

Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate.

Meissner A, Wild V, Simm R, Rohde M, Erck C, Bredenbruch F, Morr M, Römling U, Häussler S.

Environ Microbiol. 2007 Oct;9(10):2475-85.

PMID:
17803773
11.

A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties.

Ebensen T, Link C, Riese P, Schulze K, Morr M, Guzmán CA.

J Immunol. 2007 Aug 15;179(4):2065-73.

12.

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.

Ebensen T, Schulze K, Riese P, Morr M, Guzmán CA.

Clin Vaccine Immunol. 2007 Aug;14(8):952-8. Epub 2007 Jun 13.

13.

Neurophysiological indices of attention to speech in children with specific language impairment.

Shafer VL, Ponton C, Datta H, Morr ML, Schwartz RG.

Clin Neurophysiol. 2007 Jun;118(6):1230-43. Epub 2007 Apr 23.

14.

Total synthesis and biological evaluation of (-)-pectinatone employing a methyl-branched wax ester as key building block.

Galeyeva Y, Helbig S, Morr M, Sasse F, Nimtz M, Laschat S, Baro A.

Chem Biodivers. 2006 Aug;3(8):935-41.

PMID:
17193325
15.

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties.

Ebensen T, Schulze K, Riese P, Link C, Morr M, Guzmán CA.

Vaccine. 2007 Feb 9;25(8):1464-9. Epub 2006 Nov 3.

PMID:
17187906
16.

Comparison of the supramolecular structures of two glyco lipids with chiral and nonchiral methyl-branched alkyl chains from natural sources.

Milkereit G, Garamus VM, Yamashita J, Hato M, Morr M, Vill V.

J Phys Chem B. 2005 Feb 3;109(4):1599-608.

PMID:
16851131
17.
18.

Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.

Budde M, Morr M, Schmid RD, Urlacher VB.

Chembiochem. 2006 May;7(5):789-94.

PMID:
16566047
19.

Neurophysiological indexes of speech processing deficits in children with specific language impairment.

Shafer VL, Morr ML, Datta H, Kurtzberg D, Schwartz RG.

J Cogn Neurosci. 2005 Jul;17(7):1168-80.

PMID:
16138434
20.

Biosynthetic pathway of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines.

Bredenbruch F, Nimtz M, Wray V, Morr M, Müller R, Häussler S.

J Bacteriol. 2005 Jun;187(11):3630-5.

21.

Electrophysiological indices of brain activity to "the" in discourse.

Shafer VL, Kessler KL, Schwartz RG, Morr ML, Kurtzberg D.

Brain Lang. 2005 Jun;93(3):277-97. Epub 2004 Dec 8.

PMID:
15862854
22.

Synthesis and mesomorphic properties of glycosyl dialkyl- and diacyl-glycerols bearing saturated, unsaturated and methyl branched fatty acid and fatty alcohol chains. Part II. Mesomorphic properties.

Milkereit G, Brandenburg K, Gerber S, Koch MH, Morr M, Andrä J, Seydel U, Vill V.

Chem Phys Lipids. 2005 May;135(1):15-26. Epub 2005 Mar 2.

PMID:
15854622
23.
24.

A new compact disc format of high density array synthesis applied to peptide nucleic acids and in situ MALDI analysis.

Dikmans AJ, Morr M, Zander N, Adler F, Türk G, Frank R.

Mol Divers. 2004;8(3):197-207.

PMID:
15384413
25.

GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility.

Simm R, Morr M, Kader A, Nimtz M, Römling U.

Mol Microbiol. 2004 Aug;53(4):1123-34.

26.

Thermotropic and lyotropic properties of long chain alkyl glycopyranosides: part III: pH-sensitive headgroups.

Milkereit G, Morr M, Thiem J, Vill V.

Chem Phys Lipids. 2004 Jan;127(1):47-63.

PMID:
14706740
27.

Maturation of mismatch negativity: a scalp current density analysis.

Martin BA, Shafer VL, Morr ML, Kreuzer JA, Kurtzberg D.

Ear Hear. 2003 Dec;24(6):463-71.

PMID:
14663346
28.

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.

Borsutzky S, Fiorelli V, Ebensen T, Tripiciano A, Rharbaoui F, Scoglio A, Link C, Nappi F, Morr M, Buttó S, Cafaro A, Mühlradt PF, Ensoli B, Guzmán CA.

Eur J Immunol. 2003 Jun;33(6):1548-56.

29.

Differential recognition of structural details of bacterial lipopeptides by toll-like receptors.

Morr M, Takeuchi O, Akira S, Simon MM, Mühlradt PF.

Eur J Immunol. 2002 Dec;32(12):3337-47.

30.

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.

Rharbaoui F, Drabner B, Borsutzky S, Winckler U, Morr M, Ensoli B, Mühlradt PF, Guzmán CA.

Eur J Immunol. 2002 Oct;32(10):2857-65.

31.

Maturation of mismatch negativity in typically developing infants and preschool children.

Morr ML, Shafer VL, Kreuzer JA, Kurtzberg D.

Ear Hear. 2002 Apr;23(2):118-36. Review.

PMID:
11951848
32.

Synthesis and mesogenic properties of glycosyl diacylglycerols.

von Minden HM, Morr M, Milkereit G, Heinz E, Vill V.

Chem Phys Lipids. 2002 Jan;114(1):55-80.

PMID:
11841826
33.

Discrimination of bacterial lipoproteins by Toll-like receptor 6.

Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S.

Int Immunol. 2001 Jul;13(7):933-40.

PMID:
11431423
34.

Binding of nucleotides to nucleoside diphosphate kinase: a calorimetric study.

Cervoni L, Lascu I, Xu Y, Gonin P, Morr M, Merouani M, Janin J, Giartosio A.

Biochemistry. 2001 Apr 17;40(15):4583-9.

PMID:
11294625
35.

Deviant neurophysiological asymmetry in children with language impairment.

Shafer VL, Schwartz RG, Morr ML, Kessler KL, Kurtzberg D.

Neuroreport. 2000 Nov 27;11(17):3715-8.

PMID:
11117478
36.

Maturation of mismatch negativity in school-age children.

Shafer VL, Morr ML, Kreuzer JA, Kurtzberg D.

Ear Hear. 2000 Jun;21(3):242-51.

PMID:
10890733
37.
38.

Catalytic mechanism of nucleoside diphosphate kinase investigated using nucleotide analogues, viscosity effects, and X-ray crystallography.

Gonin P, Xu Y, Milon L, Dabernat S, Morr M, Kumar R, Lacombe ML, Janin J, Lascu I.

Biochemistry. 1999 Jun 1;38(22):7265-72.

PMID:
10353838
39.

In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.

Nimtz M, Grabenhorst E, Gambert U, Costa J, Wray V, Morr M, Thiem J, Conradt HS.

Glycoconj J. 1998 Sep;15(9):873-83.

PMID:
10052591
40.

Catalytic characteristics of tryparedoxin.

Gommel DU, Nogoceke E, Morr M, Kiess M, Kalisz HM, Flohé L.

Eur J Biochem. 1997 Sep 15;248(3):913-8.

41.

Acoustic neuroma.

Morr ML.

J Am Acad Audiol. 1995 Sep;6(5):396-8. No abstract available.

PMID:
8547703
42.

Effect of a single 3'-methylene phosphonate linkage on the conformation of an A-DNA octamer double helix.

Heinemann U, Rudolph LN, Alings C, Morr M, Heikens W, Frank R, Blöcker H.

Nucleic Acids Res. 1991 Feb 11;19(3):427-33.

43.

Continuous regeneration of ATP in enzyme membrane reactor for enzymatic syntheses.

Berke W, Schüz HJ, Wandrey C, Morr M, Denda G, Kula MR.

Biotechnol Bioeng. 1988 Jul 5;32(2):130-9.

PMID:
18584729
44.

Cyclic nucleotide specificity of the activator and catalytic sites of a cGMP-stimulated cGMP phosphodiesterase from Dictyostelium discoideum.

Kesbeke F, Baraniak J, Bulgakov R, Jastorff B, Morr M, Petridis G, Stec WJ, Seela F, Van Haastert PJ.

Eur J Biochem. 1985 Aug 15;151(1):179-86.

45.
46.

Investigations on stimulation of lac transcription in vivo in Escherichia coli by cAMP analogues. Biological activities and structure-activity correlations.

Scholübbers HG, van Knippenberg PH, Baraniak J, Stec WJ, Morr M, Jastorff B.

Eur J Biochem. 1984 Jan 2;138(1):101-9.

47.

Continuous regeneration of ATP for enzymatic syntheses.

Berke W, Morr M, Wandrey C, Kula MR.

Ann N Y Acad Sci. 1984;434:257-8. No abstract available.

PMID:
6098208
48.

Purification of human fibroblast interferon by extraction in aqueous two-phase systems.

Menge U, Morr M, Mayr U, Kula MR.

J Appl Biochem. 1983 Feb-Apr;5(1-2):75-90.

PMID:
6678936
49.

Derivatives of 3'- and 5'-deoxyadenosine: their inhibitory activity against DNA viruses.

Grytzmann B, Morr M, Wigand R.

Chemotherapy. 1980;26(5):316-22.

PMID:
6967001

Supplemental Content

Support Center